Stackpack Raises $6.3M to Solve the $475B Vendor Chaos Problem




Stackpack Raises $6.3M to Solve the $475B Vendor Chaos Problem

San Francisco, May 13, 2025 (GLOBE NEWSWIRE) —

Stackpack, the first intelligent Vendor Stack Management platform helping companies regain control over their growing network of third-party vendors, has raised $6.3 million. Freestyle Capital led the investment, with additional participation from Elefund, Upside Partnership, Nomad Ventures, Layout Ventures, MSIV Fund and strategic angels from Intuit, Workday, Affirm, Snapdocs and xAI.

Modern businesses are powered by a vast web of third-party providers — AI tools, SaaS platforms, contractors, and managed services. Yet most teams still manage these critical partnerships with spreadsheets, scattered documents, and crossed fingers. Stackpack is changing that.

Founded in 2023 by Sara Wyman, a veteran of Etsy and Affirm, Stackpack emerged from firsthand experience with the chaos and cost of unmanaged vendors. Wyman saw how missed renewals, redundant tools, and growing compliance risks could quietly drain budgets and introduce operational risk — and recognized that the vendors powering a business were as essential to its success as its internal team.

With Stackpack, finance and IT teams get a single source of truth for all third-party vendors – automatically surfacing renewal dates, contract owners, shadow IT, compliance gaps, and savings opportunities. The platform uses AI to not only uncover blind spots, but also acts on behalf of customers as an agent to ensure nothing falls through the cracks. Ultimately, Stackpack turns vendor sprawl into strategic advantage.

“The majority of companies aren’t managing the entities that power them,” said Sara Wyman, founder of Stackpack. “Companies think of themselves as ‘people-first’ – but today they’re ‘vendor-first’. There are typically 6x more vendors than employees at the average U.S. company, and that number is quickly increasing. And there isn’t a system to manage that shift.”

The early team behind Stackpack includes early leaders from PayPal, eBay, Adobe, Asana, Twilio, and Google — operators uniquely positioned to build a networked platform and scale it from early stage to market leadership.

Stackpack enters the market at a critical moment: Over $475 billion is spent annually on third-party software and services in the U.S. alone, with an estimated 25% of it going unused. Payroll budgets are shifting to outsourced contractors and AI expense. Compliance risks are multiplying as third-party vendors handle sensitive data. A lack of transparency in renewal dates and pricing are wrecking budgets and forecasts. Today’s finance and IT teams need real-time visibility, automated guardrails, and tighter controls more than ever, and Stackpack is building the platform for this new era.

“Every vendor decision today carries financial, legal, and privacy implications — it’s a C-suite concern,” said Dave Samuel, General Partner at Freestyle Capital. “You wouldn’t manage employees or customers in spreadsheets, so why are we still doing that for vendors? Stackpack is automating the entire vendor lifecycle – from discovery and evaluation to renewals – bringing visibility, control, and strategic oversight to every stage. With this foundation in place, they’re uniquely positioned to connect buyers and sellers in smarter, more transparent partnerships.”

Just months after launch, Stackpack is already managing over 10,500 vendors and $510 million in spend across more than 50 customers, including Every Man Jack, Rho, Density, HouseRx, Fexa, and ZeroEyes.

For finance leaders, the value is simple and provides the ultimate financial insurance. “The CFO is on the hook when something gets missed. Stackpack means we don’t have to cross our fingers every quarter,” said Brandon Lee, Accounting Manager at BizzyCar. At Stride Health, Controller Arthur Wei articulated the problem clearly: “Vendor buying is decentralized – but it comes back to the finance team to manage financial health and reporting.”

Alongside its core Stack Management platform, Stackpack is now expanding beyond visibility with a second product: Requests & Approvals, currently in beta. Designed as a lightweight, affordable alternative to platforms like Zip and Coupa, it gives teams a faster way to evaluate and approve vendor requests. Over time, Stackpack also plans to help customers discover and evaluate new partners.

Looking ahead, Stackpack’s mission is to help companies connect with the right partners, at the right time, on the right terms – transforming vendor management into a strategic capability. “This isn’t just a finance problem,” said Wyman. “It’s a foundational shift. We not only need to be the eyes and ears to help companies reduce cost and risk, but also find the right tools for their budget and size. Managing your vendors and partners should be as strategic as managing your talent – vendor ecosystems are the next major competitive edge.”

Ends 

Media images can be found here. 

About Stackpack
Stackpack is the first AI-native platform built to manage the accelerating costs, risks, and complexity of third-party vendors, AI tools, and contractors. It gives finance and IT teams a single source of truth to control spend, manage renewals, and reduce compliance risk across the entire vendor lifecycle. As external ecosystems grow, Stackpack turns vendor chaos into strategic clarity. For more information please visit: https://www.stackpack.ai/ or follow via LinkedIn

About Freestyle
Freestyle Capital is an early-stage venture capital firm managing over $565 million in assets with investments in 150+ technology companies, including a few notable names like Airtable, Intercom, Patreon, and BetterUp. Founded in 2009, Freestyle was one of the first firms to specialize exclusively in seed-stage investing, uniquely led by founders turned VCs. To learn more about Freestyle, please visit http://freestyle.vc

CONTACT: For further information please contact the Stackpack press office: on press@stackpack.ai 

PeakMetrics Appoints Noha Georges to Its Board of Advisors




PeakMetrics Appoints Noha Georges to Its Board of Advisors

LOS ANGELES, May 08, 2025 (GLOBE NEWSWIRE) — PeakMetrics, a leader in AI-driven narrative intelligence, is pleased to announce the appointment of Noha Georges to its Board of Advisors. Georges brings over two decades of global experience in strategic communications, reputation management, and public affairs, with deep expertise in both the Middle East and North Africa (MENA). Her addition to the advisory board marks a significant step in PeakMetrics’ mission to expand its reach and enhance its intelligence offering across regions.

Georges is a seasoned executive with a proven track record of advising top-tier organizations, governments, and Fortune 500 companies. Throughout her career, she has led high-impact communications strategies for organizations such as Deloitte, Ogilvy, and Qatar Central Bank, shaping business narratives and managing reputational risks on a global scale. Her expertise spans corporate communications, executive coaching, crisis response, and digital marketing, making her an invaluable asset to PeakMetrics’ growth and expansion efforts.

“Noha’s strategic insight and deep understanding of communications challenges on a global scale make her an exceptional addition to our advisory board,” said Nick Loui, Co-Founder & CEO of PeakMetrics. “Her experience in both the public and private sectors across MENA will be instrumental as we continue to enhance our platform’s capabilities and expand our ability to service customers internationally.”

In her role, Georges will advise PeakMetrics on strategic communications, government relations, and market expansion across MENA, helping to strengthen the company’s capabilities and tailor its offering to better address the region’s unique information environment, AI-driven threats, and evolving influence dynamics.

“I am thrilled to join PeakMetrics at such a pivotal time in its growth journey,” said Noha Georges. “The ability to detect and defend against emerging narratives is critical for organizations worldwide. I look forward to contributing to PeakMetrics’ mission and supporting its expansion into new markets.”

Georges has been recognized with multiple industry awards, including the Platinum Hermes Creative Award in Content Innovation and a Silver Stevie Award in Digital Marketing. She is a sought-after speaker and thought leader on corporate reputation and crisis management.

For more information about PeakMetrics and its AI-driven narrative intelligence platform, visit www.peakmetrics.com.

About PeakMetrics

PeakMetrics provides a cutting-edge narrative intelligence solution designed to help government entities and organizations proactively detect, decipher, and defend against malign influence and adversarial information campaigns. Leveraging advanced narrative ML technology, PeakMetrics identifies emerging narratives in real time, assesses their impact to prioritize the most pressing threats, and delivers actionable response plans to support mission-critical decision-making. Organizations rely on PeakMetrics to counter foreign influence, mitigate deceptive media, and strengthen resilience against evolving information threats.

Media Contact:
Jessica Pratt
PeakMetrics
jessica@peakmetrics.com

While AI makes writing code easier than ever, CodeAnt AI secures $2M to make it easy to review




While AI makes writing code easier than ever, CodeAnt AI secures $2M to make it easy to review

Y Combinator-backed startup brings AI to code reviews, helping engineering teams cut manual code review time and bugs by over 50%.

California, May 07, 2025 (GLOBE NEWSWIRE) — AI might be great at helping engineers write code, but it’s creating a new problem – all that code still needs to be reviewed by humans. CodeAnt AI is stepping in with a solution that uses AI to tackle the review process itself, raising $2 million in seed funding to help engineering teams move faster without sacrificing quality or security.

The funding, CodeAnt AI’s first institutional round, values the company at $20 million. It will be used to expand the engineering and business development teams and to scale CodeAnt AI’s code quality and application security platform. For engineering teams already feeling the pressure to ship faster, the investment comes at the perfect time.

The funding round was led by Y Combinator, VitalStage Ventures, and Uncorrelated Ventures, and with participation from DeVC, Transpose Platform, Entrepreneur First, and a number of marquee angel investors.

CodeAnt AI founders: Amartya Jha and Chinmay Bharti.

“As AI-driven coding becomes widespread, the real bottleneck isn’t writing code — it’s reviewing it,” said Amartya Jha, Co-founder and CEO of CodeAnt AI. “Today, when a developer submits a change request, it often sits idle for hours or even days waiting for peer review. And even when a reviewer does pick it up, they rarely have full context of the code change. This is a critical risk point: most software bugs and vulnerabilities slip through at the peer review stage, where issues could have been caught early and cheaply.”

AI Code Review In Action with CodeAnt AI.

CodeAnt AI’s platform plugs right into GitHub, GitLab, Bitbucket, and Azure DevOps, giving developers instant feedback on their code across more than 30 programming languages. More impressively, it doesn’t just find problems – it suggests fixes that developers can apply with a single click, turning reviews that used to take hours into proactive quick, five-minute sessions. For companies racing to get products out the door, this means fewer delays and higher quality code. It also means cost savings – fixing problems during code reviews costs 10x less compared to fixing them later during CI/CD or after production deployments. 

CodeAnt AI dashboard. 

“We now have a new team member: CodeAnt AI. It sees our entire codebase in seconds, catches what linters miss, and suggests optimizations, refactors, even typos. It’s fully integrated into our on-prem GitLab — and the whole team adopted it instantly” said Michel Naud, Head of IT Solutions, Autajon Group. While, Sundaraman Venkataramani, Tech Lead at Motorq added:“At Motorq, speed, quality and precision are paramount. CodeAnt AI’s Agile team mirrors our fast-paced environment, delivering rapid iterations and responsive support. Their AI-driven code reviews, real-time feedback and robust security features have streamlined our development process allowing us to focus on core domain challenges. With CodeAnt AI, We’ve already been able to enhance code quality, security and are pushing our boundaries of innovation”.

The company was founded by Amartya Jha and Chinmay Bharti, who both saw the same problem from different angles. Jha worked on scaling infrastructure at Zeta and ShareChat, where he noticed how easily critical bugs slipped through when reviews weren’t thorough. Bharti, with a master’s specialising in AI from IIT Bombay, faced similar issues while building high-frequency trading software at Blu Analytics – where a single bug could have serious financial consequences. Together, they built CodeAnt AI and were accepted into Y Combinator.

What makes CodeAnt AI different is the technology under the hood. The company built  a proprietary language-agnostic AST engine that actually understands how different parts of a codebase connect, letting it spot issues that isolated code reviews would miss. The platform also pulls in data from major security databases and lets companies set up their own rules based on their specific needs. For security-conscious organizations, CodeAnt AI can run entirely within their own infrastructure, ensuring code never leaves their environment.

“In today’s AI-driven environment, enterprises need solutions that either replace aging systems or deliver clear productivity gains,” added Amartya Jha. “CodeAnt AI is built to do both — helping companies move faster and stay competitive without compromising on security or code quality.”

Tom Blomfield, Partner at Y Combinator added: “With more and more code being generated by AI, code review has never been more important. CodeAnt fits into your CI/CD pipeline and ensures that only high-quality code makes it into production. Not AI-generated slop!”

Pricing starts at $10 per developer per month for the basic AI code review features, with a full package including code quality, security, and compliance tools available for $40 per developer per month.

As AI continues to transform how code gets written, CodeAnt AI is positioning itself as the bridge to a future where code can be both rapidly created and confidently deployed. The founders envision a world where AI doesn’t just help developers write code faster, but also ensures that every line shipped to production is secure, efficient, and ready for the real world – giving engineering teams the confidence to move at the speed their businesses demand.

Meanwhile, early investor at Hubspot Brian Shin, Managing Partner for VitalStage Ventures, commented: “CodeAnt AI is redefining one of the most critical — and often overlooked — parts of modern software development: the code review. In a world where AI is rapidly democratizing code generation, the bottleneck has shifted to validation. CodeAnt’s platform slashes review time by over 50%, ensuring not just speed, but quality, security, and reliability at scale. This leap forward empowers engineering teams to ship faster while catching issues earlier — a foundational advantage in today’s software-driven economy.”

Code review and code quality are becoming super critical for teams to measure, track and improve. Especially with the rapid pace of adoption of AI for code generation. CodeAnt AI has built a great product that many engineering leaders swear by already added Aakash Kumar, General Partner at DeVc.

“I love that CodeAnt stands on the shoulders of giants such as Sonar,” said Salil Deshpande, General Partner at Uncorrelated Ventures. “CodeAnt not only integrates into enterprise environments to help deliver clean, consistent, and reliable code, but also dramatically speeds up code reviews by identifying and fixing issues early during the review process — one of the most manual and critical parts of software development today.”

Alex Bangash, Partner at Transpose Platform commented: “CodeAnt is enabling software engineering focused on creativity and innovation, not time consuming mundane yet important tasks. The automation is slick but they are keeping human reviewers in the loop. For a future where many PRs will be written by coding assistants, having a software engineering “empowerment” platform like CodeAnt will become even more critical to ensure performant, secure, and innovative software solutions.”

Ends 

Media images can be found here.

About CodeAnt AI
CodeAnt AI is an AI code reviewer that fixes code quality issues and security vulnerabilities. It’s proven to help enterprises reduce manual code review time by over 50%. 

CodeAnt AI integrates directly across the development workflow—from IDEs to pull requests to CI/CD—offering one-click fixes for code quality and security issues. CodeAnt AI does this via: 

• AI Code Review: Automatically reviews each pull request, summarizes changes, flags issues, and offers one-click fixes.
• Code Quality Platform: Continuously scans the entire codebase for code smells, dead/ duplicate/ complex code, adds docstrings, and provides real-time quality insights.
• Code Security Platform: Continuously monitors code, infra, and dependencies, detects vulnerabilities and secrets, and offers real-time security insights.

CodeAnt AI is SOC 2 & HIPAA compliant and trusted by teams ranging from small startups to large unicorns. For more information please visit https://www.codeant.ai/ or follow via X or LinkedIn.

CONTACT: For further information please contact the CodeAnt AI press office: Amartya Jha on press@codeant.ai 

While AI makes writing code easier than ever, CodeAnt AI secures $2M to make it easy to review




While AI makes writing code easier than ever, CodeAnt AI secures $2M to make it easy to review

Y Combinator-backed startup brings AI to code reviews, helping engineering teams cut manual code review time and bugs by over 50%.

California, May 07, 2025 (GLOBE NEWSWIRE) — AI might be great at helping engineers write code, but it’s creating a new problem – all that code still needs to be reviewed by humans. CodeAnt AI is stepping in with a solution that uses AI to tackle the review process itself, raising $2 million in seed funding to help engineering teams move faster without sacrificing quality or security.

The funding, CodeAnt AI’s first institutional round, values the company at $20 million. It will be used to expand the engineering and business development teams and to scale CodeAnt AI’s code quality and application security platform. For engineering teams already feeling the pressure to ship faster, the investment comes at the perfect time.

The funding round was led by Y Combinator, VitalStage Ventures, and Uncorrelated Ventures, and with participation from DeVC, Transpose Platform, Entrepreneur First, and a number of marquee angel investors.

CodeAnt AI founders: Amartya Jha and Chinmay Bharti.

“As AI-driven coding becomes widespread, the real bottleneck isn’t writing code — it’s reviewing it,” said Amartya Jha, Co-founder and CEO of CodeAnt AI. “Today, when a developer submits a change request, it often sits idle for hours or even days waiting for peer review. And even when a reviewer does pick it up, they rarely have full context of the code change. This is a critical risk point: most software bugs and vulnerabilities slip through at the peer review stage, where issues could have been caught early and cheaply.”

AI Code Review In Action with CodeAnt AI.

CodeAnt AI’s platform plugs right into GitHub, GitLab, Bitbucket, and Azure DevOps, giving developers instant feedback on their code across more than 30 programming languages. More impressively, it doesn’t just find problems – it suggests fixes that developers can apply with a single click, turning reviews that used to take hours into proactive quick, five-minute sessions. For companies racing to get products out the door, this means fewer delays and higher quality code. It also means cost savings – fixing problems during code reviews costs 10x less compared to fixing them later during CI/CD or after production deployments. 

CodeAnt AI dashboard. 

“We now have a new team member: CodeAnt AI. It sees our entire codebase in seconds, catches what linters miss, and suggests optimizations, refactors, even typos. It’s fully integrated into our on-prem GitLab — and the whole team adopted it instantly” said Michel Naud, Head of IT Solutions, Autajon Group. While, Sundaraman Venkataramani, Tech Lead at Motorq added:“At Motorq, speed, quality and precision are paramount. CodeAnt AI’s Agile team mirrors our fast-paced environment, delivering rapid iterations and responsive support. Their AI-driven code reviews, real-time feedback and robust security features have streamlined our development process allowing us to focus on core domain challenges. With CodeAnt AI, We’ve already been able to enhance code quality, security and are pushing our boundaries of innovation”.

The company was founded by Amartya Jha and Chinmay Bharti, who both saw the same problem from different angles. Jha worked on scaling infrastructure at Zeta and ShareChat, where he noticed how easily critical bugs slipped through when reviews weren’t thorough. Bharti, with a master’s specialising in AI from IIT Bombay, faced similar issues while building high-frequency trading software at Blu Analytics – where a single bug could have serious financial consequences. Together, they built CodeAnt AI and were accepted into Y Combinator.

What makes CodeAnt AI different is the technology under the hood. The company built  a proprietary language-agnostic AST engine that actually understands how different parts of a codebase connect, letting it spot issues that isolated code reviews would miss. The platform also pulls in data from major security databases and lets companies set up their own rules based on their specific needs. For security-conscious organizations, CodeAnt AI can run entirely within their own infrastructure, ensuring code never leaves their environment.

“In today’s AI-driven environment, enterprises need solutions that either replace aging systems or deliver clear productivity gains,” added Amartya Jha. “CodeAnt AI is built to do both — helping companies move faster and stay competitive without compromising on security or code quality.”

Tom Blomfield, Partner at Y Combinator added: “With more and more code being generated by AI, code review has never been more important. CodeAnt fits into your CI/CD pipeline and ensures that only high-quality code makes it into production. Not AI-generated slop!”

Pricing starts at $10 per developer per month for the basic AI code review features, with a full package including code quality, security, and compliance tools available for $40 per developer per month.

As AI continues to transform how code gets written, CodeAnt AI is positioning itself as the bridge to a future where code can be both rapidly created and confidently deployed. The founders envision a world where AI doesn’t just help developers write code faster, but also ensures that every line shipped to production is secure, efficient, and ready for the real world – giving engineering teams the confidence to move at the speed their businesses demand.

Meanwhile, early investor at Hubspot Brian Shin, Managing Partner for VitalStage Ventures, commented: “CodeAnt AI is redefining one of the most critical — and often overlooked — parts of modern software development: the code review. In a world where AI is rapidly democratizing code generation, the bottleneck has shifted to validation. CodeAnt’s platform slashes review time by over 50%, ensuring not just speed, but quality, security, and reliability at scale. This leap forward empowers engineering teams to ship faster while catching issues earlier — a foundational advantage in today’s software-driven economy.”

Code review and code quality are becoming super critical for teams to measure, track and improve. Especially with the rapid pace of adoption of AI for code generation. CodeAnt AI has built a great product that many engineering leaders swear by already added Aakash Kumar, General Partner at DeVc.

“I love that CodeAnt stands on the shoulders of giants such as Sonar,” said Salil Deshpande, General Partner at Uncorrelated Ventures. “CodeAnt not only integrates into enterprise environments to help deliver clean, consistent, and reliable code, but also dramatically speeds up code reviews by identifying and fixing issues early during the review process — one of the most manual and critical parts of software development today.”

Alex Bangash, Partner at Transpose Platform commented: “CodeAnt is enabling software engineering focused on creativity and innovation, not time consuming mundane yet important tasks. The automation is slick but they are keeping human reviewers in the loop. For a future where many PRs will be written by coding assistants, having a software engineering “empowerment” platform like CodeAnt will become even more critical to ensure performant, secure, and innovative software solutions.”

Ends 

Media images can be found here.

About CodeAnt AI
CodeAnt AI is an AI code reviewer that fixes code quality issues and security vulnerabilities. It’s proven to help enterprises reduce manual code review time by over 50%. 

CodeAnt AI integrates directly across the development workflow—from IDEs to pull requests to CI/CD—offering one-click fixes for code quality and security issues. CodeAnt AI does this via: 

• AI Code Review: Automatically reviews each pull request, summarizes changes, flags issues, and offers one-click fixes.
• Code Quality Platform: Continuously scans the entire codebase for code smells, dead/ duplicate/ complex code, adds docstrings, and provides real-time quality insights.
• Code Security Platform: Continuously monitors code, infra, and dependencies, detects vulnerabilities and secrets, and offers real-time security insights.

CodeAnt AI is SOC 2 & HIPAA compliant and trusted by teams ranging from small startups to large unicorns. For more information please visit https://www.codeant.ai/ or follow via X or LinkedIn.

CONTACT: For further information please contact the CodeAnt AI press office: Amartya Jha on press@codeant.ai 

ReportAId raises €2.2M using AI to unlock healthcare data




ReportAId raises €2.2M using AI to unlock healthcare data

Italian startup turns unstructured medical reports into actionable care plans, unlocking up to 25% revenue increases for hospitals.

Milan, May 06, 2025 (GLOBE NEWSWIRE) — Ask any doctor what’s keeping them from delivering better care, and paperwork will top the list. Despite billions invested in healthcare technology, 80% of clinical data remains trapped in unstructured reports, and 70% of patients don’t return to the same facility for follow-ups. Today, ReportAId announces a €2.2 million pre-seed funding round to address this massive inefficiency with an AI platform that automatically interprets medical reports and transforms them into interactive tools that guide both patients and clinicians through personalized care pathways.

The capital raise was led by Italian Founders Fund with participation from Heartfelt, Exceptional Ventures, 2100 Ventures, Vento, Ithaca, B Heroes, Vesper Holding, and angel investors Luca Ascani, Enrico Giacomelli, Francesco Zaccariello and Luca Foschini. This investment will enable ReportAId to add ten new team members and expand across Italian and European healthcare, scaling a solution already in use at leading institutions like San Raffaele Hospital and currently being adopted by Ospedale Isola Tiberina – Gemelli Isola.

ReportAId founders: (L to R) Claudio Caletti, Giuseppe Faraci and Luca Foresti.

“ReportAId is the first operator to bring AI at scale into Italian healthcare. In the coming years, this technology will become a core pillar of the health system,” said Giuseppe Faraci, CEO and co-founder of ReportAId. “We already work with leading private providers, but our goal is to support the public sector as well. We are ready for a concrete dialogue with local-health directors, regional councillors and national ministries to help modernise the NHS.”

ReportAId’s platform tackles the root causes of healthcare inefficiency: poorly managed reports, fragmented care journeys, and difficulties in treatment planning. The AI-powered system extracts key data from medical documents and creates structured, personalized care plans that make next steps clear for everyone involved. For patients, this means quick, guided access to every aspect of their care pathway – streamlining appointment booking, medication purchases, and follow-up care. For providers, the platform enables more efficient scheduling of tests and surgeries, design of therapeutic and preventive plans, and assessment of prescription appropriateness in line with clinical guidelines.

Founded in Milan in 2024 by Giuseppe Faraci (CEO), Claudio Caletti (CTO) and Luca Foresti (Chairman), ReportAId emerged from the founders’ firsthand observations of the critical inefficiencies plaguing healthcare. By applying AI to the fundamental problem of unstructured clinical data, they’ve created a solution that not only improves the patient experience but also delivers significant operational benefits to healthcare providers – with revenue increases of up to 25% reported by hospitals using the system.

What differentiates ReportAId is its focus on turning unactionable medical reports into structured databases and automated workflows while maintaining full compliance with EU privacy regulations. The platform’s ability to create a comprehensive clinical database covering every medical report gives healthcare facilities unprecedented insight into their operations and patient outcomes.

The ReportAId platform.

“ReportAId is one of the most tangible and transformative AI applications in healthcare. It tackles critical inefficiencies – from fragmented clinical data and gaps in patient management to structural waiting-list issues,” said Irene Mingozzi, Principal at Italian Founders Fund. “By turning medical reports into structured, automated actions, the platform directly improves continuity and quality of care. This is exactly the kind of impact IFF seeks: ambitious founders, enabling technology and a long-term vision to make things better. We also believe ReportAId’s potential extends far beyond Italy.”

The healthcare AI sector has seen explosive growth, but few solutions address the fundamental data structuring problem that ReportAId tackles. With proven traction at prestigious institutions like San Raffaele Hospital and a clear path to both private and public sector adoption, the company is positioned to become a critical infrastructure layer in the European healthcare system.

“Healthcare is the perfect field for AI, and the founders – already well-known in the AI and health ecosystem – are attacking one of the sector’s biggest inefficiencies with a simple, elegant and scalable solution,” added Paolo Pio, Co-Founder & General Partner at Exceptional Ventures. “Traction in Italy is real and demand is knocking. We’re excited to join their mission.”

Looking ahead, ReportAId plans to expand its integration capabilities with existing healthcare IT systems, develop additional AI capabilities for specialized medical disciplines, and work directly with public healthcare authorities to implement its solution at scale – creating a more efficient, accessible healthcare system that serves patients better while reducing costs and administrative burdens.

Ends 

Media images can be found here.

About ReportAId
Founded in Milan in 2024 by Giuseppe Faraci (CEO), Claudio Caletti (CTO) and Luca Foresti (Chairman), ReportAId leverages artificial intelligence to optimise healthcare processes, automatically interpreting medical reports and turning them into interactive tools for providers and patients—fully compliant with European privacy regulations. Backed by Italian Founders Fund, Heartfelt, Exceptional Ventures, 2100 Ventures, Vento, Ithaca, B Heroes, Vesper Holding, Luca Ascani, Enrico Giacomelli, Francesco Zaccariello and Luca Foschini, the solution is live or being rolled out at private hospitals including San Raffaele and Ospedale Isola Tiberina – Gemelli Isola. ReportAId now aims to serve the public sector, helping make healthcare systems more efficient and accessible.

CONTACT: For more information please contact ReportAId via press@reportaid.ai

ReportAId raises €2.2M using AI to unlock healthcare data




ReportAId raises €2.2M using AI to unlock healthcare data

Italian startup turns unstructured medical reports into actionable care plans, unlocking up to 25% revenue increases for hospitals.

Milan, May 06, 2025 (GLOBE NEWSWIRE) — Ask any doctor what’s keeping them from delivering better care, and paperwork will top the list. Despite billions invested in healthcare technology, 80% of clinical data remains trapped in unstructured reports, and 70% of patients don’t return to the same facility for follow-ups. Today, ReportAId announces a €2.2 million pre-seed funding round to address this massive inefficiency with an AI platform that automatically interprets medical reports and transforms them into interactive tools that guide both patients and clinicians through personalized care pathways.

The capital raise was led by Italian Founders Fund with participation from Heartfelt, Exceptional Ventures, 2100 Ventures, Vento, Ithaca, B Heroes, Vesper Holding, and angel investors Luca Ascani, Enrico Giacomelli, Francesco Zaccariello and Luca Foschini. This investment will enable ReportAId to add ten new team members and expand across Italian and European healthcare, scaling a solution already in use at leading institutions like San Raffaele Hospital and currently being adopted by Ospedale Isola Tiberina – Gemelli Isola.

ReportAId founders: (L to R) Claudio Caletti, Giuseppe Faraci and Luca Foresti.

“ReportAId is the first operator to bring AI at scale into Italian healthcare. In the coming years, this technology will become a core pillar of the health system,” said Giuseppe Faraci, CEO and co-founder of ReportAId. “We already work with leading private providers, but our goal is to support the public sector as well. We are ready for a concrete dialogue with local-health directors, regional councillors and national ministries to help modernise the NHS.”

ReportAId’s platform tackles the root causes of healthcare inefficiency: poorly managed reports, fragmented care journeys, and difficulties in treatment planning. The AI-powered system extracts key data from medical documents and creates structured, personalized care plans that make next steps clear for everyone involved. For patients, this means quick, guided access to every aspect of their care pathway – streamlining appointment booking, medication purchases, and follow-up care. For providers, the platform enables more efficient scheduling of tests and surgeries, design of therapeutic and preventive plans, and assessment of prescription appropriateness in line with clinical guidelines.

Founded in Milan in 2024 by Giuseppe Faraci (CEO), Claudio Caletti (CTO) and Luca Foresti (Chairman), ReportAId emerged from the founders’ firsthand observations of the critical inefficiencies plaguing healthcare. By applying AI to the fundamental problem of unstructured clinical data, they’ve created a solution that not only improves the patient experience but also delivers significant operational benefits to healthcare providers – with revenue increases of up to 25% reported by hospitals using the system.

What differentiates ReportAId is its focus on turning unactionable medical reports into structured databases and automated workflows while maintaining full compliance with EU privacy regulations. The platform’s ability to create a comprehensive clinical database covering every medical report gives healthcare facilities unprecedented insight into their operations and patient outcomes.

The ReportAId platform.

“ReportAId is one of the most tangible and transformative AI applications in healthcare. It tackles critical inefficiencies – from fragmented clinical data and gaps in patient management to structural waiting-list issues,” said Irene Mingozzi, Principal at Italian Founders Fund. “By turning medical reports into structured, automated actions, the platform directly improves continuity and quality of care. This is exactly the kind of impact IFF seeks: ambitious founders, enabling technology and a long-term vision to make things better. We also believe ReportAId’s potential extends far beyond Italy.”

The healthcare AI sector has seen explosive growth, but few solutions address the fundamental data structuring problem that ReportAId tackles. With proven traction at prestigious institutions like San Raffaele Hospital and a clear path to both private and public sector adoption, the company is positioned to become a critical infrastructure layer in the European healthcare system.

“Healthcare is the perfect field for AI, and the founders – already well-known in the AI and health ecosystem – are attacking one of the sector’s biggest inefficiencies with a simple, elegant and scalable solution,” added Paolo Pio, Co-Founder & General Partner at Exceptional Ventures. “Traction in Italy is real and demand is knocking. We’re excited to join their mission.”

Looking ahead, ReportAId plans to expand its integration capabilities with existing healthcare IT systems, develop additional AI capabilities for specialized medical disciplines, and work directly with public healthcare authorities to implement its solution at scale – creating a more efficient, accessible healthcare system that serves patients better while reducing costs and administrative burdens.

Ends 

Media images can be found here.

About ReportAId
Founded in Milan in 2024 by Giuseppe Faraci (CEO), Claudio Caletti (CTO) and Luca Foresti (Chairman), ReportAId leverages artificial intelligence to optimise healthcare processes, automatically interpreting medical reports and turning them into interactive tools for providers and patients—fully compliant with European privacy regulations. Backed by Italian Founders Fund, Heartfelt, Exceptional Ventures, 2100 Ventures, Vento, Ithaca, B Heroes, Vesper Holding, Luca Ascani, Enrico Giacomelli, Francesco Zaccariello and Luca Foschini, the solution is live or being rolled out at private hospitals including San Raffaele and Ospedale Isola Tiberina – Gemelli Isola. ReportAId now aims to serve the public sector, helping make healthcare systems more efficient and accessible.

CONTACT: For more information please contact ReportAId via press@reportaid.ai

Eascra Biotech Expands Operations with a New Worcester Lab




Eascra Biotech Expands Operations with a New Worcester Lab

Nanomedicine startup to conduct research and testing in the MBI facility

BOSTON, May 01, 2025 (GLOBE NEWSWIRE) — Eascra Biotech announced their first commercial lab, a preclinical startup space within the Massachusetts Biomedical Initiatives (MBI) facility in Worcester, MA. The lab marks a significant milestone in the company’s mission to advance life science research and expand work on their JBNps (Janus base nanoparticles), a new type of non-lipid nanoparticle delivery platform that mimics DNA.

The 300-square-foot facility located at 17 Briden Street, Worcester, MA, is part of the Massachusetts Biomedical Initiative (MBI). MBI is the longest-running non-profit life sciences incubator in the Commonwealth.

Eascra’s lab team will conduct advanced testing as this location will serve as Eascra’s operational headquarters for partner collaboration projects, grant-funded project work, and post space flight sample analysis. The lab will also be the center of pre-clinical Earth research, gathering data for pre-IND discussions with the FDA and executing partner/grant-funded project work.

“Our new lab is an exciting step for Eascra as we continue to push boundaries on Earth and in space,” said Mari Anne Snow, co-founder and CEO. “This lab is Eascra’s first independent lab designed to scale research and development efforts and strengthen partnerships in the life science ecosystem. We will continue to advance our technology so we can achieve our goal of bringing it to market to help patients in need.”

Eascra’s proprietary technology, pioneered by co-founder Dr. Yupeng Chen, can deliver RNA therapeutics to hard-to-reach places like cartilage, kidneys and hard tumors. The long, slender JBNps give better cell penetration than most delivery methods, leading to more effective treatment delivery.

About Eascra Biotech
Eascra Biotech (eascrabiotech.com) is an early-stage nanomedicine startup providing an advanced therapeutic delivery platform capable of delivering nucleotides, gene editing, and other therapeutics to hard-to-reach treatment sites, such as articular cartilage, kidneys and solid tumors. Our mission is to advance our technology for the benefit of humankind. Eascra’s proprietary delivery mechanism, a Janus Base Nanoparticle (JBNp) invented by Eascra co-founder, Dr. Yupeng Chen, mimics DNA and is customizable for different treatment indications. Eascra is working with NASA, the ISS National Laboratory™, and a variety of private space companies to accelerate our go-to-market strategy. We are actively seeking commercial partnerships with companies in need of innovative delivery mechanisms to expedite the development of cutting-edge treatments that enhance patient outcomes.

CONTACT: Media Contact:
Bobbie Carlton
Carlton PR & Marketing LLC
Bobbie@carltonprmarketing.com
781-718-7619

Eascra Biotech Expands Operations with a New Worcester Lab




Eascra Biotech Expands Operations with a New Worcester Lab

Nanomedicine startup to conduct research and testing in the MBI facility

BOSTON, May 01, 2025 (GLOBE NEWSWIRE) — Eascra Biotech announced their first commercial lab, a preclinical startup space within the Massachusetts Biomedical Initiatives (MBI) facility in Worcester, MA. The lab marks a significant milestone in the company’s mission to advance life science research and expand work on their JBNps (Janus base nanoparticles), a new type of non-lipid nanoparticle delivery platform that mimics DNA.

The 300-square-foot facility located at 17 Briden Street, Worcester, MA, is part of the Massachusetts Biomedical Initiative (MBI). MBI is the longest-running non-profit life sciences incubator in the Commonwealth.

Eascra’s lab team will conduct advanced testing as this location will serve as Eascra’s operational headquarters for partner collaboration projects, grant-funded project work, and post space flight sample analysis. The lab will also be the center of pre-clinical Earth research, gathering data for pre-IND discussions with the FDA and executing partner/grant-funded project work.

“Our new lab is an exciting step for Eascra as we continue to push boundaries on Earth and in space,” said Mari Anne Snow, co-founder and CEO. “This lab is Eascra’s first independent lab designed to scale research and development efforts and strengthen partnerships in the life science ecosystem. We will continue to advance our technology so we can achieve our goal of bringing it to market to help patients in need.”

Eascra’s proprietary technology, pioneered by co-founder Dr. Yupeng Chen, can deliver RNA therapeutics to hard-to-reach places like cartilage, kidneys and hard tumors. The long, slender JBNps give better cell penetration than most delivery methods, leading to more effective treatment delivery.

About Eascra Biotech
Eascra Biotech (eascrabiotech.com) is an early-stage nanomedicine startup providing an advanced therapeutic delivery platform capable of delivering nucleotides, gene editing, and other therapeutics to hard-to-reach treatment sites, such as articular cartilage, kidneys and solid tumors. Our mission is to advance our technology for the benefit of humankind. Eascra’s proprietary delivery mechanism, a Janus Base Nanoparticle (JBNp) invented by Eascra co-founder, Dr. Yupeng Chen, mimics DNA and is customizable for different treatment indications. Eascra is working with NASA, the ISS National Laboratory™, and a variety of private space companies to accelerate our go-to-market strategy. We are actively seeking commercial partnerships with companies in need of innovative delivery mechanisms to expedite the development of cutting-edge treatments that enhance patient outcomes.

CONTACT: Media Contact:
Bobbie Carlton
Carlton PR & Marketing LLC
Bobbie@carltonprmarketing.com
781-718-7619

DePoly to launch 500-tonne-per-year showcase plant to give yesterday’s plastics a new purpose, as it secures $23M




DePoly to launch 500-tonne-per-year showcase plant to give yesterday’s plastics a new purpose, as it secures $23M

Swiss cleantech scale-up prepares to demonstrate industrial-scale implementation of its revolutionar

Zurich, April 29, 2025 (GLOBE NEWSWIRE) — Every year, millions of tons of PET and polyester waste end up in landfills or are incinerated, yet sustainable recycling solutions remain limited. Today, DePoly – the leading sustainable PET-to-raw-material recycling company – announces the upcoming launch of a 500-tonne-per-year showcase plant in Monthey, Switzerland this summer, representing a critical step in the company’s journey from laboratory breakthrough to industrial-scale implementation.

The facility will demonstrate DePoly’s proprietary process that converts PET and polyester waste into virgin-quality raw materials without fossil fuels. Imagine a world where discarded items – from polyester shirts to water bottles – are not wasted anymore but resources transformed back into the building blocks for new products. After all, revolutionizing an industry isn’t just about creating new technology – it’s about proving it works at scale.

DePoly co-founders (L to R) Christopher Ireland, Samantha Anderson and Bardiya Valizadeh.

DePoly’s technology has already demonstrated its commercial impact through collaborations with some of the world’s leading companies—not only in fashion, like Odlo, but also in cosmetics and the broader consumer goods industry, including innovators such as PTI. Through these partnerships, DePoly has validated the quality of its recycled monomers by transforming PET waste into new bottles, high-performance textile fibers, and cosmetic packaging. This proves that DePoly’s recycled materials can meet, and even exceed, the highest standards of purity and performance across a wide range of industries.

By delivering oil-equivalent monomers, DePoly’s technology sets a new benchmark for circularity, offering a genuine alternative to virgin materials. “The upcoming showcase plant validates our roadmap to creating a truly circular plastics market. Following our pilot and showcase plant, our next goal is to scale our operations to industrial size with a first of a kind commercial plant based on our technology,” said Samantha Anderson, Co-founder & CEO of DePoly.

DePoly is ramping up with world-class innovators, bold thinkers and cutting-edge know-how—taking their pilot victory to industrial scale demands nothing less than unstoppable ambition.The company is planning to build a commercial plant in 2027 that will process significantly larger volumes of PET and polyester waste – a major leap in redefining recycling and advancing the circular economy, as DePoly strives to become the global leader in sustainable, circular plastics.

Shredded PET samples.

To further accelerate this expansion, DePoly has secured a total of $23 million in seed funding with MassMutual Ventures joining a second closing of its round. The expanded investor base positions DePoly as one of the biggest recycling technology companies in Europe, with more than $30 million raised across two rounds and grants. MassMutual Ventures joins existing investors, including Founderful, ACE & Company, Angel Invest, Zürcher Kantonalbank, BASF Venture Capital, Beiersdorf Venture Capital, and Syensqo.

“DePoly’s proven technology is a game changer addressing a crucial industrial and societal challenge. This raise and the showcase plant opening are advancing DePoly’s position as a leader in plastics recycling,” said Alix Brunet, Europe Lead at MassMutual Ventures.

David Hanf, who joined DePoly in 2024 as CFO, brings extensive experience from European scale-ups including Smava and Thermondo—Germany’s largest B2C heat service company. Both an entrepreneur and an executive, he adds: “We are convinced our technology is one of the fastest to scale and will allow us to compete with virgin pricing at scale, a key factor for success. We are happy to have expanded our investor base to the US with MassMutual Ventures as we want to build a global champion.”

By transforming discarded plastics into high-quality raw materials, DePoly reduces reliance on fossil resources, minimizes waste, and paves the way for a circular materials industry. Recognized as a Technology Pioneer by the World Economic Forum and a winner of the 2024 Top 100 Swiss Startup Award, DePoly proves that sustainable innovation is not only possible – it’s happening now.

Ends

Media images can be found here. 

About DePoly
DePoly is a cleantech company transforming polyester and PET waste into valuable raw materials. Using patented technology, DePoly breaks down plastic and textile waste into the building blocks for new, high-quality PET and polyester—reducing waste, cutting reliance on fossil fuels, and advancing circularity across multiple industries. DePoly was named a 2024 Technology Pioneer by the World Economic Forum and won the Top 100 Swiss Startup Award in 2024. Learn more at www.depoly.co.

About MassMutual Ventures 
MassMutual Ventures (MMV) is a multistage global venture capital firm investing in climate technology, financial technology, enterprise SaaS, healthtech and cybersecurity companies. With teams based in London, Singapore, and Boston, MMV manages over $1 billion in investment capital across the globe. We help accelerate the growth of the companies we partner with by providing capital, connections, and advice. With our deep expertise and extensive network, MMV helps entrepreneurs build compelling and scalable companies of value. For more information, visit www.massmutualventures.com/. 

CONTACT: For further information, please contact the DePoly team at media@depoly.co

eeden Closes €18M Series A Financing to Scale its Breakthrough Textile Recycling Technology




eeden Closes €18M Series A Financing to Scale its Breakthrough Textile Recycling Technology

Münster, 29.04.2025 – German tech startup eeden, which has developed a groundbreaking textile recycling technology, announces the completion of its €18 million Series A funding round. The round was led by Forbion, a leading venture capital firm based in The Netherlands, through its BioEconomy Fund. Also joining as new investors are Henkel Ventures, the strategic venture capital fund of Henkel, with deep expertise in surface and coating technologies through its consumer and industrial business, and NRW.Venture, the Venture Fund of NRW.BANK, North Rhine-Westphalia´s development bank. All existing investors reinvested in the round, including the venture capital investors TechVision Fund (TVF), High-Tech Gründerfonds (HTGF) and D11Z. Ventures – the early-stage investment arm of the family office of Dieter Schwarz. The funding will enable eeden to build its demonstration plant in Münster, optimize large-scale processing, and establish commercial projects with key players in the textile industry.

Steffen Gerlach (CEO & Co-Founder) & Dr. Tobias Börnhost (CTO & Co-Founder) of eeden. (Photo © eeden) 

A major step toward circularity

Ongoing challenges including rising costs, scarcity of resources, material volatility, and growing regulatory hurdles continue to strain the textile industry. To remain competitive, brands and manufacturers are increasingly looking for textile materials that combine high performance, scalability, and circularity at price parity. eeden addresses this need with its breakthrough in chemical recycling technology that recovers pure cellulose and PET building blocks (monomers) from cotton-polyester blends. Their products can be used to produce virgin-quality lyocell, viscose, and polyester fibers thereby offering a resource-efficient alternative to conventional fibers and unlocking new circular value chains.

Steffen Gerlach, CEO & Co-Founder of eeden: “Over the past few years, we have developed a proven solution that has the potential to meet the industry’s long-term need for cost-efficient and high-performing circular materials. We are proud that our new and existing investors believe in our approach and share our vision. With their support, we are ready to scale our technology and turn textile waste into materials the industry truly needs.”

With increasing textile waste comes increased regulation. As of January 2025, EU member states are required to implement separate collection systems for used textiles. eeden’s technology provides a pragmatic solution that is capable of processing complex blended materials.

Alex Hoffmann, General Partner at Forbion noted, “eeden has developed a pioneering solution that can make large-scale textile recycling not only technologically feasible, but also commercially viable in the near future. We see tremendous potential in their approach and are excited to support the team as they bring this breakthrough technology to industrial scale.”

Björn Lang, Partner TVF, “As an early investor, it’s great to see how the team has turned a vision into a validated process and strong strategic partnerships. The progress they’ve made shows what’s possible when the right people and strong science meet real customer needs. We’re excited to keep backing the team as they scale their impact.”

The new eeden demonstration facility in Münster, Germany follows the successful technology validation of its pilot plant with industrial partners. This €18 million Series A financing will enable the company to optimize large-scale processing and establish commercial projects with key players in the textile industry.

ENDS

About eeden

About Forbion

About Henkel Ventures

About NRW.Venture

About TVF

About D11Z. Ventures

About HTGF – High-Tech Gründerfonds

Press Contact: Julian Hertrampf, hertrampf@eeden.world, +49 251 2979 3366

Attachment

• eeden – Series A – l. Steffen Gerlach, CEO & Co-Founder – r. Dr. Tobias Börnhost, CTO & Co-Founder